U.S. Representative Jackie Walorski (R-Ind.), a pro-life leader in Congress, released the following statement on President Joe Biden’s executive action expanding abortion access following the Dobbs v. Jackson Women’s Health Organization ruling:
“With Roe relegated to the history books, President Biden is conspiring with the pro-abortion lobby to remove guardrails on chemical abortion and expand loopholes. Abortion pills are the dangerous next frontier of a movement that celebrates abortion on-demand and on the taxpayers’ dime,” said Congresswoman Walorski. “As President Biden uses his pen to encourage abortion by mail, American women deserve to know the true cost of these drugs. Women who take abortion pills are ending up in emergency rooms – or worse – due to dangerous side effects. To safeguard women’s lives, I am fighting to strengthen transparency at the FDA and ensure that Americans have clear access to the truth.”
Earlier this spring, Congresswoman Walorski introduced H.R. 6702, the Safeguarding Women’s and Children’s Health Act of 2022, to require more accurate reporting of abortion drug prescribing and related adverse side effects and events.
Current law lacks mandatory reporting of abortion drug adverse events, leaving accurate statistics and data unknown. The Safeguarding Women’s and Children’s Health Act would require health care providers – including abortion providers and the emergency medical professionals who most often treat women following a botched chemical abortion – to report any death or adverse event related to abortion drugs to both the U.S. Food and Drug Administration (FDA) and the drug manufacturer. It would also require that all information compiled on these drugs be made publicly and easily accessible on the FDA’s website.
Read more about the Safeguarding Women’s and Children’s Health Act of 2022 here.
Article provided by Congresswoman Walorski’s office
